{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:59:43Z","timestamp":1765609183704},"reference-count":52,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2709,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,2,5]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>There has been a dramatic rise in incidences of Barrett\u2019s oesophagus and oesophageal adenocarcinoma. It has been suggested that the introduction and use of acid suppression therapy may be a factor in the rising incidences of Barrett\u2019s oesophagus and oesophageal adenocarcinoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>This was a record linkage study, using a prescribing database and an endoscopy database. Patients who had undergone their first endoscopy during the period 1992\u20131995 and received the diagnosis of Barrett\u2019s oesophagus or oesophagitis were identified. The prescribing of acid suppressants was compared for the 3\u2003years prior to endoscopy, between those with Barrett\u2019s oesophagus and those with oesophagitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>There was no significant difference between the Barrett\u2019s patients and the oesophagitis patients in the proportion that had been exposed to acid suppression therapy (53.4% vs. 51.7%, <jats:italic>P<\/jats:italic>=0.704). The mean number of days of prescribing among those who had been exposed to acid suppression therapy was higher in the Barrett\u2019s group (340.5 vs. 237.0\u2003days, <jats:italic>P<\/jats:italic>=0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Patients with Barrett\u2019s oesophagus have received more acid suppressant therapy prior to diagnosis. The reasons for this are not clear. However, 46.6% of Barrett\u2019s patients have not been exposed to acid suppressant therapy.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.00914.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:43:42Z","timestamp":1047354222000},"page":"221-226","source":"Crossref","is-referenced-by-count":4,"title":["The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett\u2019s oesophagus and oesophagitis"],"prefix":"10.1111","volume":"15","author":[{"given":"J. A.","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Weston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.84"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90420-H"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460100089030"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.314"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/70.1.1"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.5"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(84)90090-8","article-title":"Adenocarcinoma and Barrett\u2019s esophagus. An overrated risk?","volume":"87","author":"Spechler SJ","year":"1984","journal-title":"Gastroenterology"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510033131404"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63269-2"},{"key":"e_1_2_7_12_2","first-page":"A45","article-title":"Changing incidence of columnar lined (Barrett\u2019s) oesophagus (CLO) in the UK","volume":"44","author":"Watson A","year":"1999","journal-title":"Gut"},{"key":"e_1_2_7_13_2","first-page":"537","article-title":"Gastroesophageal reflux and adenocarcinoma of the esophagus","volume":"341","author":"Marcus G","year":"1999","journal-title":"N Engl J Med"},{"key":"e_1_2_7_14_2","first-page":"279","article-title":"Management of Barrett\u2019s esophagus free of dysplasia","volume":"9","author":"De Meester SR","year":"1997","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"e_1_2_7_15_2","first-page":"764","article-title":"Alkaline gastroesophageal reflux: implications in the development of complications in Barrett\u2019s columnar\u2010lined esophagus","volume":"106","author":"Attwood SEA","year":"1989","journal-title":"Surg"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199522240-00010"},{"key":"e_1_2_7_17_2","unstructured":"MacDonaldTM&McDevittDG.The Tayside Medicines Monitoring Unit (MEMO). In: Strom BL ed. Pharmacoepidemiology 2nd edn. Chichester UK: Wiley 1994: 245\u201355."},{"key":"e_1_2_7_18_2","first-page":"177","article-title":"The Tayside Medicines Monitoring Unit (MEMO): a record\u2010linkage system for pharmacovigilance","volume":"9","author":"Evans JMM","year":"1995","journal-title":"Pharm Med"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-5223(19)33854-1","article-title":"Functional foregut abnormalities in Barrett\u2019s esophagus","volume":"105","author":"Stein HJ","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90017-S"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.649"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/iai.36.2.518-524.1982","article-title":"Effect of cimetidine and antacid on gastric microbial flora","volume":"36","author":"Snepar R","year":"1982","journal-title":"Infect Immunol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6447.717"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(80)92826-3","article-title":"Effect of cimetidine on the gastric bacterial flora","volume":"1","author":"Ruddell WSJ","year":"1980","journal-title":"Lancet"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.54"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02208680"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.4.455"},{"key":"e_1_2_7_29_2","first-page":"462","article-title":"Alteration of bile acid metabolism by cimetidine in healthy humans","volume":"44","author":"Shindo K","year":"1996","journal-title":"J Invest Med"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.2.266"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018806431866"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/01635589809514689"},{"key":"e_1_2_7_33_2","first-page":"2353","article-title":"A bile acid induced apoptosis assay for colon cancer risk and associated quality control studies","volume":"59","author":"Bernstein C","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_7_34_2","doi-asserted-by":"crossref","unstructured":"VisleA BjornstadE OpheimP&SkarsteinA et\u2003al.Risk of carcinoma following gastric operations for benign disease. A study of 3470 patients.Lancet1986:502\u20135.","DOI":"10.1016\/S0140-6736(86)90368-5"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.12.1447"},{"key":"e_1_2_7_36_2","first-page":"503","article-title":"Duodenogastric reflux and the development of oesophageal adenocarcinoma in rats","volume":"111","author":"Attwood SEA","year":"1992","journal-title":"Surgery"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02071396"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199609000-00012"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70492-0"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90258-M"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109025038"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529008997622"},{"key":"e_1_2_7_43_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0016-5085(85)90521-9","article-title":"Effects of cimetidine and ranitidine on interdigestive and postprandial lower esophageal sphincter pressures and plasma gastrin levels in normal subjects","volume":"88","author":"Smout AJ","year":"1985","journal-title":"Gastroenterology"},{"key":"e_1_2_7_44_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0016-5085(19)32867-7","article-title":"Mucosal DNA synthesis: a short term index of the trophic action of gastrin","volume":"61","author":"Johnson LR","year":"1974","journal-title":"Gastroenterology"},{"key":"e_1_2_7_45_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0016-5085(77)80003-6","article-title":"New aspects of the trophic action of gastrointestinal hormones","volume":"72","author":"Johnson LR","year":"1977","journal-title":"Gastroenterology"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198202000-00017"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(85)80006-4"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1986.01400030039006"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800750416"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910915)68:6<1255::AID-CNCR2820680613>3.0.CO;2-N"},{"key":"e_1_2_7_51_2","first-page":"7179","article-title":"Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines","volume":"48","author":"Hoosein NM","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_7_52_2","first-page":"880","article-title":"Gastrimmune raises antibodies that neutralise amidated and glycine extended Gastrin\u201017 and inhibit the growth of colon cancer","volume":"56","author":"Watson SA","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_7_53_2","first-page":"A658","article-title":"Gastrin\u2014a potential therapeutic target in oesophageal adenocarcinoma and Barrett\u2019s oesophagus","volume":"112","author":"Smith AM","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00914.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.00914.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.00914.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:34:16Z","timestamp":1697506456000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.00914.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,5]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2,5]]}},"alternative-id":["10.1046\/j.1365-2036.2001.00914.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.00914.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,5]]}}}